UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 171

Sortiert nach

The Danish nationwide clinical register for patients with rheumatoid arthritis: DANBIO

Clinical epidemiology, 2016-01, Vol.8, p.737-742

2016

Volltextzugriff (PDF)

Delayed identification of disseminated infection in a patient with rheumatoid arthritis and septic arthritis: a case report

Scandinavian journal of rheumatology, 2024, Vol.53 (1), p.72-73

2024

Volltextzugriff (PDF)

Characteristics of participants and decliners from a randomized controlled trial on physical activity in patients with rheumatoid arthritis: a retrospective register-based cross-sectional study

Scandinavian journal of rheumatology, 2023-01, Vol.52 (1), p.17-24

2023

Volltextzugriff (PDF)

Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers

Annals of the rheumatic diseases, 2017-02, Vol.76 (2), p.386

2017

Volltextzugriff (PDF)

Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries

Annals of the rheumatic diseases, 2011-09, Vol.70 (9), p.1575-1580

2011

Volltextzugriff (PDF)

Uptake and effectiveness of newer biologic and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritis: results from five Nordic biologics registries

Annals of the rheumatic diseases, 2023-06, Vol.82 (6), p.820

2023

Volltextzugriff (PDF)

Cancer risk in patients with spondyloarthritis treated with TNF inhibitors: a collaborative study from the ARTIS and DANBIO registers

Annals of the rheumatic diseases, 2017-01, Vol.76 (1), p.105

2017

Volltextzugriff (PDF)

Pregnancy outcomes in relation to disease activity and anti-rheumatic treatment strategies in women with rheumatoid arthritis: a matched cohort study from Sweden and Denmark

Rheumatology (Oxford, England), 2022-08, Vol.61 (9), p.3711-3722

2022

Volltextzugriff (PDF)

Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration

Annals of the rheumatic diseases, 2019-11, Vol.78 (11), p.1536

2019

Volltextzugriff (PDF)

Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative project

Annals of the rheumatic diseases, 2017-12, Vol.76 (12), p.2025

2017

Volltextzugriff (PDF)

Comparison of treatment retention and response to secukinumab versus tumour necrosis factor inhibitors in psoriatic arthritis

Rheumatology (Oxford, England), 2021, Vol.60 (8), p.3635-3645

2021

Volltextzugriff (PDF)

EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update

Annals of the rheumatic diseases, 2024-03, Vol.83 (6), p.706

2024

Volltextzugriff (PDF)

Real‐World Six‐ and Twelve‐Month Drug Retention, Remission, and Response Rates of Secukinumab in 2,017 Patients With Psoriatic Arthritis in Thirteen European Countries

Arthritis care & research (2010), 2022-07, Vol.74 (7), p.1205-1218

2022

Volltextzugriff (PDF)

Risk of Staphylococcus aureus bacteraemia in patients with rheumatoid arthritis and the effect of orthopaedic implants on the risk: a nationwide observational cohort study

Scandinavian journal of rheumatology, 2023-05, Vol.52 (3), p.250-258

2023

Volltextzugriff (PDF)

Methotrexate Safety and Efficacy in Combination Therapies in Patients With Early Rheumatoid Arthritis: A Post Hoc Analysis of a Randomized Controlled Trial

Arthritis & rheumatology (Hoboken, N.J.), 2024-03, Vol.76 (3), p.363-376

2024

Volltextzugriff (PDF)

Extremely poor patient-reported outcomes are associated with lack of clinical response and decreased retention rate of tumour necrosis factor inhibitor treatment in patients with axial spondyloarthritis

Scandinavian journal of rheumatology, 2019-03, Vol.48 (2), p.128-132

2019

Volltextzugriff (PDF)

Is the risk of infection higher during treatment with secukinumab than with TNF inhibitors? An observational study from the Nordic countries

Rheumatology (Oxford, England), 2023-02, Vol.62 (2), p.647-658

2023

Volltextzugriff (PDF)

Increased synovial galectin-3 induce inflammatory fibroblast activation and osteoclastogenesis in patients with rheumatoid arthritis

Scandinavian journal of rheumatology, 2023-01, Vol.52 (1), p.33-41

2023

Volltextzugriff (PDF)

Increased soluble programmed death-1 (sPD-1) is associated with disease activity and radiographic progression in early rheumatoid arthritis

Scandinavian journal of rheumatology, 2014-03, Vol.43 (2), p.101-108

2014

Volltextzugriff (PDF)

Validation and assessment of minimally clinically important difference of the unadjusted Health Assessment Questionnaire in a Danish cohort: uncovering ordinal bias

Scandinavian journal of rheumatology, 2020-01, Vol.49 (1), p.1-7

2020

Volltextzugriff (PDF)

Serum 14-3-3η as predictor of clinical remission and progression of structural damage in early rheumatoid arthritis following a treat-to-target strategy in a randomized controlled trial

Scandinavian journal of rheumatology, 2023-07, Vol.52 (4), p.342-352

2023

Volltextzugriff (PDF)

SP0176 Measuring outcomes in a busy practice

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.43-43

Hetland, M.L.

2013

Volltextzugriff (PDF)

Baseline serum levels of IgA anti-cyclic citrullinated protein antibodies in early rheumatoid arthritis predict radiographic progression after 11 years of treatment: a secondary analysis of the CIMESTRA study

Scandinavian journal of rheumatology, 2023-09, Vol.52 (5), p.493-497

2023

Volltextzugriff (PDF)

1 – 25 von 171

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(164)
Mit Volltextzugriff
(155)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(92)
Life Sciences & Biomedicine
(88)
Medicin Och Hälsovetenskap
(86)
Rheumatology
(73)
Humans
(61)
Male
(38)
Female
(37)
Middle Aged
(35)
Rheumatoid Arthritis
(29)
Adult
(27)
Antirheumatic Agents - Therapeutic Use
(27)
Arthritis, Rheumatoid - Drug Therapy
(27)
Patients
(21)
Treatment Outcome
(20)
Reumatologi Och Inflammation
(19)
Rheumatology And Autoimmunity
(19)
Aged
(18)
Epidemiology
(15)
Tumor Necrosis Factor-Tnf
(15)
Clinical Medicine
(14)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registries

The Danish nationwide clinical register for patients with rheumatoid arthritis: DANBIO

Delayed identification of disseminated infection in a patient with rheumatoid arthritis and septic arthritis: a case report

Characteristics of participants and decliners from a randomized controlled trial on physical activity in patients with rheumatoid arthritis: a retrospective register-based cross-sectional study

Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers

Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries

Uptake and effectiveness of newer biologic and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritis: results from five Nordic biologics registries

Cancer risk in patients with spondyloarthritis treated with TNF inhibitors: a collaborative study from the ARTIS and DANBIO registers

Pregnancy outcomes in relation to disease activity and anti-rheumatic treatment strategies in women with rheumatoid arthritis: a matched cohort study from Sweden and Denmark

Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration

Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative project

Comparison of treatment retention and response to secukinumab versus tumour necrosis factor inhibitors in psoriatic arthritis

EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update

Real‐World Six‐ and Twelve‐Month Drug Retention, Remission, and Response Rates of Secukinumab in 2,017 Patients With Psoriatic Arthritis in Thirteen European Countries

Risk of Staphylococcus aureus bacteraemia in patients with rheumatoid arthritis and the effect of orthopaedic implants on the risk: a nationwide observational cohort study

Methotrexate Safety and Efficacy in Combination Therapies in Patients With Early Rheumatoid Arthritis: A Post Hoc Analysis of a Randomized Controlled Trial

Extremely poor patient-reported outcomes are associated with lack of clinical response and decreased retention rate of tumour necrosis factor inhibitor treatment in patients with axial spondyloarthritis

Is the risk of infection higher during treatment with secukinumab than with TNF inhibitors? An observational study from the Nordic countries

Increased synovial galectin-3 induce inflammatory fibroblast activation and osteoclastogenesis in patients with rheumatoid arthritis

Increased soluble programmed death-1 (sPD-1) is associated with disease activity and radiographic progression in early rheumatoid arthritis

Validation and assessment of minimally clinically important difference of the unadjusted Health Assessment Questionnaire in a Danish cohort: uncovering ordinal bias

One‐Year Treatment Outcomes of Secukinumab Versus Tumor Necrosis Factor Inhibitors in Spondyloarthritis: Results From Five Nordic Biologic Registries Including More Than 10,000 Treatment Courses

Serum 14-3-3η as predictor of clinical remission and progression of structural damage in early rheumatoid arthritis following a treat-to-target strategy in a randomized controlled trial

SP0176 Measuring outcomes in a busy practice

Baseline serum levels of IgA anti-cyclic citrullinated protein antibodies in early rheumatoid arthritis predict radiographic progression after 11 years of treatment: a secondary analysis of the CIMESTRA study

Suchergebnisse filtern